References
- Brady RO: Cerebral lipidoses. Annu Rev Med 21: 317–334, 1970
- Yatsu FM: Sphingolipidoses. Calif Med 114: 1–6, 1971
- Brady RO: Biochemical and metabolic basis of familial sphingolipidoses. Semin Hematol 9: 273–284, 1972
- Brady RO, Pentchev PG, Gal AE, et al: Replacement therapy for inherited enzyme deficiency. N Engl J Med 291: 989–993, 1974
- Percy AK: Antenatal detection of the sphingolipidoses. N Engl J Med 288: 1405–1406, 1973
- Schneck L, Amsterdam D, Volk BW: Antenatal diagnosis and therapeutic trends in sphingolipidoses. JAMA 228: 615–618, 1974
- Svennerholm L: Chromatographic separation of human brain gangliosides. J Neurochem 10: 613–623, 1963
- O'Brien JS: Ganglioside-storage diseases. N Engl J Med 284: 893–896, 1971
- Crocker AC: The cerebral defect in Tay-Sachs disease and Niemann-Pick disease. J Neurochem 7: 69–80, 1961
- Dawson G, Stein AO: Lactosyl ceramidosis: Catabolic enzyme defect of glycosphingolipid metabolism. Science 170: 556–558, 1970
- Kint JA: Fabry's disease: Alpha-galactosidase deficiency. Science 167: 1268–1269, 1970
- Sandhoff K, Andreae U, Jatzkewitz H: Deficient hexosaminidase activity in an exceptional case of Tay-Sachs disease with additional storage of kidney globoside in visceral organs. Life Sci 7: 283–288, 1968
- Sandhoff K, Harzer K, Wässle W, et al: Enzyme alterations and lipid storage in three variants of Tay-Sachs disease. J Neurochem 18: 2469–2489, 1971
- Durand P, Borrone C, Della Cella G: Fucosidosis. J Pediatr 75: 665–674, 1969
- Dawson G, Spranger JW: Fucosidosis: A glycosphin- golipidosis. N Engl J Med 285: 122, 1971
- Max SR, Maclaren NK, Brady RO, et al: GM3 (hematoside) sphingolipodystrophy. N Engl J Med 291: 929–931, 1974
- O'Brien JS: Synthetic defect in ganglioside synthesis. (Editorial) N Engl J Med 291: 975–976, 1974